Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: LIVZON PHARMA(01513) the Revenue is 2.457 B (-27.39%), Miss estimate;the EBIT is 551.99 M (-31.33%), Miss estimate;the EPS is 0.462 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
2.46B27.39%
3.41B0.74%
-0.95B28.13%
EBITMiss expectations
0.55B31.33%
0.88B9.72%
-0.33B41.05%
EPSMiss expectations
0.4617--
0.7386--
-0.2769--%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf